Skip Navigation



Brain Advance Access published online on February 27, 2006

Brain, doi:10.1093/brain/awl044
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
129/5/1306    most recent
awl044v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lin, W.
Right arrow Articles by Popko, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, W.
Right arrow Articles by Popko, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2006). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received October 6, 2005
Revised January 24, 2006
Accepted January 27, 2006

Article

Interferon-{gamma} inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress

Wensheng Lin 1, April Kemper 2, Jeffrey L. Dupree 3, Heather P. Harding 4, David Ron 4, and Brian Popko 1 *

1 Department of Neurology, Jack Miller Center for Peripheral Neuropathy, University of Chicago, Chicago, IL, USA
2 Department of Pathology, Wake Forest University Baptist Medical Center, Winston-Salem, NC, USA
3 Department of Anatomy and Neurobiology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA
4 The Skirball Institute, New York University School of Medicine, New York, NY, USA

* To whom correspondence should be addressed.
Brian Popko, E-mail: bpopko{at}neurology.bsd.uchicago.edu


   Abstract

Interferon-{gamma} (IFN-{gamma}) is believed to play a deleterious role in the immune-mediated demyelinating disorder multiple sclerosis. Here we have exploited transgenic mice that ectopically express IFN-{gamma} in a temporally controlled manner in the CNS to specifically study its effects on remyelination in the cuprizone-induced demyelination model and in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis. CNS delivery of IFN-{gamma} severely suppressed remyelination in both models and impaired the clinical recovery of the mice experiencing EAE. These observations correlated with a dramatic reduction of oligodendroglial repopulation in the demyelinated lesions. Moreover, we found that in cuprizone-treated mice the detrimental actions of IFN-{gamma} were associated with endoplasmic reticulum (ER) stress in remyelinating oligodendrocytes. Compared with a wild-type genetic background, the presence of IFN-{gamma} in mice heterozygous for a loss of function mutation in the pancreatic ER kinase (PERK), a kinase that responds specifically to ER stress, further reduced the percentage of remyelinated axons and oligodendrocyte numbers in cuprizone-induced demyelinated lesions. Thus, these data suggest that IFN-{gamma} is capable of inhibiting remyelination in demyelinated lesions and that ER stress modulates the response of remyelinating oligodendrocytes to this cytokine.

Keywords: ER stress; interferon-{gamma}; oligodendrocyte; PERK; remyelination.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
JEMHome page
J. Das, G. Ren, L. Zhang, A. I. Roberts, X. Zhao, A. L.M. Bothwell, L. Van Kaer, Y. Shi, and G. Das
Transforming growth factor {beta} is dispensable for the molecular orchestration of Th17 cell differentiation
J. Exp. Med., October 26, 2009; 206(11): 2407 - 2416.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
W. Lin, P. E. Kunkler, H. P. Harding, D. Ron, R. P. Kraig, and B. Popko
Enhanced Integrated Stress Response Promotes Myelinating Oligodendrocyte Survival in Response to Interferon-{gamma}
Am. J. Pathol., November 1, 2008; 173(5): 1508 - 1517.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Dubois-Dalcq, A. Williams, C. Stadelmann, B. Stankoff, B. Zalc, and C. Lubetzki
From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases
Brain, July 1, 2008; 131(7): 1686 - 1700.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. R. Lees, Y. Iwakura, and J. H. Russell
Host T Cells Are the Main Producers of IL-17 within the Central Nervous System during Initiation of Experimental Autoimmune Encephalomyelitis Induced by Adoptive Transfer of Th1 Cell Lines
J. Immunol., June 15, 2008; 180(12): 8066 - 8072.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
H.T. Ghashghaei, J. M. Weimer, R. S. Schmid, Y. Yokota, K. D. McCarthy, B. Popko, and E.S. Anton
Reinduction of ErbB2 in astrocytes promotes radial glial progenitor identity in adult cerebral cortex
Genes & Dev., December 15, 2007; 21(24): 3258 - 3271.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Antony, K. K. Ellestad, R. Hammond, K. Imaizumi, F. Mallet, K. G. Warren, and C. Power
The Human Endogenous Retrovirus Envelope Glycoprotein, Syncytin-1, Regulates Neuroinflammation and Its Receptor Expression in Multiple Sclerosis: A Role for Endoplasmic Reticulum Chaperones in Astrocytes
J. Immunol., July 15, 2007; 179(2): 1210 - 1224.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. Balabanov, K. Strand, R. Goswami, E. McMahon, W. Begolka, S. D. Miller, and B. Popko
Interferon-{gamma}-Oligodendrocyte Interactions in the Regulation of Experimental Autoimmune Encephalomyelitis
J. Neurosci., February 21, 2007; 27(8): 2013 - 2024.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. Balabanov, K. Strand, A. Kemper, J. Y. Lee, and B. Popko
Suppressor of cytokine signaling 1 expression protects oligodendrocytes from the deleterious effects of interferon-gamma.
J. Neurosci., May 10, 2006; 26(19): 5143 - 5152.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.